(Q52941540)

9 May 2018

title

Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. (English)

1 reference

9 May 2018

7

Vera Regitz-Zagrosek

1 reference

9 May 2018

6

Roland Hetzer

1 reference

9 May 2018

Reinhard Pregla

5

object named as

Reinhard Pregla

1 reference

9 May 2018

Jens Fielitz

1

object named as

Jens Fielitz

1 reference

9 May 2018

author name string

Manuela Leuschner

2

1 reference

9 May 2018

Heinz Renee Zurbrügg

3

1 reference

9 May 2018

Britta Hannack

4

1 reference

9 May 2018

publication date

19 November 2004

1 reference

9 May 2018

Journal of Molecular Medicine

published in

1 reference

9 May 2018

volume

82

1 reference

9 May 2018

issue

12

1 reference

9 May 2018

page(s)

809-820

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s00109-004-0606-4

exact match

0 references

cites work

TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-004-0606-4

Activation mechanisms of matrix metalloproteinases.

21 January 2018

1 reference

12 December 2020

Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?

1 reference

12 December 2020

Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling

1 reference

12 December 2020

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)

1 reference

12 December 2020

Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure

1 reference

12 December 2020

Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression

1 reference

12 December 2020

Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease

1 reference

12 December 2020

Preclinical and clinical studies of MMP inhibitors in cancer

1 reference

12 December 2020

Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation

1 reference

12 December 2020

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

12 December 2020

Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase

1 reference

12 December 2020

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice

1 reference

12 December 2020

Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function

1 reference

12 December 2020

Differential expression of tissue inhibitors of metalloproteinases in the failing human heart

1 reference

12 December 2020

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

1 reference

12 December 2020

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

1 reference

12 December 2020

Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement

1 reference

12 December 2020

Matrix metalloproteinases and their inhibitors

1 reference

12 December 2020

Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer

1 reference

12 December 2020

Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells

1 reference

12 December 2020

Matrix metalloproteinases

1 reference

12 December 2020

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

1 reference

12 December 2020

Cytokine regulation of metalloproteinase gene expression

1 reference

12 December 2020

Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression

1 reference

12 December 2020

Extracellular matrix gene expression in the left ventricular tissue of spontaneously hypertensive rats

1 reference

12 December 2020

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure

1 reference

12 December 2020

Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4

1 reference

12 December 2020

Regulation of collagen degradation in the rat myocardium after infarction

1 reference

12 December 2020

Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease

1 reference

12 December 2020

Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation

1 reference

12 December 2020

Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression

1 reference

12 December 2020

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

12 December 2020

Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation

1 reference

12 December 2020

Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease.

1 reference

12 December 2020

Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions

1 reference

12 December 2020

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

1 reference

12 December 2020

Matrix metalloproteinases: regulation and dysregulation in the failing heart

1 reference

12 December 2020

Region- and Type-Specific Induction of Matrix Metalloproteinases in Post–Myocardial Infarction Remodeling

1 reference

12 December 2020

How matrix metalloproteinases regulate cell behavior

1 reference

12 December 2020

Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.

1 reference

12 December 2020

Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.

1 reference

12 December 2020

MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition

1 reference

12 December 2020

Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control

1 reference

12 December 2020

Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links.

1 reference

12 December 2020

The matrix strikes back: evidence for autoregulatory mechanisms in metalloproteinase regulation

1 reference

12 December 2020

Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA 3'-UTR control element DICE.

1 reference

12 December 2020

Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes

1 reference

12 December 2020

Collagenolytic Enzymes and Their Naturally Occurring Inhibitors

1 reference

12 December 2020

Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis

1 reference

12 December 2020

Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling

1 reference

12 December 2020

Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases

1 reference

12 December 2020

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

12 December 2020

10.1007/S00109-004-0606-4

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018